Literature DB >> 10068683

The intracellular serpin proteinase inhibitor 6 is expressed in monocytes and granulocytes and is a potent inhibitor of the azurophilic granule protease, cathepsin G.

F L Scott1, C E Hirst, J Sun, C H Bird, S P Bottomley, P I Bird.   

Abstract

The monocyte and granulocyte azurophilic granule proteinases elastase, proteinase 3, and cathepsin G are implicated in acute and chronic diseases thought to result from an imbalance between the secreted proteinase(s) and circulating serpins such as alpha1-proteinase inhibitor and alpha1-antichymotrypsin. We show here that the intracellular serpin, proteinase inhibitor 6 (PI-6), is present in monocytes, granulocytes, and myelomonocytic cell lines. In extracts from these cells, PI-6 bound an endogenous membrane-associated serine proteinase to form an sodium dodecyl sulfate (SDS)-stable complex. Using antibodies to urokinase, elastase, proteinase 3, or cathepsin G, we demonstrated that the complex contains cathepsin G. Native cathepsin G and recombinant PI-6 formed an SDS-stable complex in vitro similar in size to that observed in the extracts. Further kinetic analysis demonstrated that cathepsin G and PI-6 rapidly form a tight 1:1 complex (ka = 6.8 +/- 0.2 x 10(6) mol/L-1s-1 at 17 degrees C; Ki = 9.2 +/- 0.04 x 10(-10) mol/L). We propose that PI-6 complements alpha1-proteinase inhibitor and alpha1-antichymotrypsin (which control extracellular proteolysis) by neutralizing cathepsin G that leaks into the cytoplasm of monocytes or granulocytes during biosynthesis or phagocytosis. Control of intracellular cathepsin G may be particularly important, because it has recently been shown to activate the proapoptotic proteinase, caspase-7.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10068683

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  21 in total

1.  From hematopoiesis to neuropoiesis: evidence of overlapping genetic programs.

Authors:  A V Terskikh; M C Easterday; L Li; L Hood; H I Kornblum; D H Geschwind; I L Weissman
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-03       Impact factor: 11.205

2.  Murine serpin 2A is a redox-sensitive intracellular protein.

Authors:  Emma C Morris; Timothy R Dafforn; Sharon L Forsyth; Melinda A Missen; Anita J Horvath; Lynne Hampson; Ian N Hampson; Graeme Currie; Robin W Carrell; Paul B Coughlin
Journal:  Biochem J       Date:  2003-04-01       Impact factor: 3.857

3.  A truncating mutation in SERPINB6 is associated with autosomal-recessive nonsyndromic sensorineural hearing loss.

Authors:  Asli Sirmaci; Seyra Erbek; Justin Price; Mingqian Huang; Duygu Duman; F Başak Cengiz; Güney Bademci; Suna Tokgöz-Yilmaz; Burcu Hişmi; Hilal Ozdağ; Banu Oztürk; Sevsen Kulaksizoğlu; Erkan Yildirim; Haris Kokotas; Maria Grigoriadou; Michael B Petersen; Hashem Shahin; Moien Kanaan; Mary-Claire King; Zheng-Yi Chen; Susan H Blanton; Xue Z Liu; Stephan Zuchner; Nejat Akar; Mustafa Tekin
Journal:  Am J Hum Genet       Date:  2010-05-06       Impact factor: 11.025

Review 4.  Neutrophil elastase, proteinase 3, and cathepsin G as therapeutic targets in human diseases.

Authors:  Brice Korkmaz; Marshall S Horwitz; Dieter E Jenne; Francis Gauthier
Journal:  Pharmacol Rev       Date:  2010-12       Impact factor: 25.468

5.  Nucleocytoplasmic distribution of the ovalbumin serpin PI-9 requires a nonconventional nuclear import pathway and the export factor Crm1.

Authors:  C H Bird; E J Blink; C E Hirst; M S Buzza; P M Steele; J Sun; D A Jans; P I Bird
Journal:  Mol Cell Biol       Date:  2001-08       Impact factor: 4.272

6.  Cathepsin G Inhibition by Serpinb1 and Serpinb6 Prevents Programmed Necrosis in Neutrophils and Monocytes and Reduces GSDMD-Driven Inflammation.

Authors:  Sabrina Sofia Burgener; Nathan Georges François Leborgne; Scott J Snipas; Guy S Salvesen; Phillip Ian Bird; Charaf Benarafa
Journal:  Cell Rep       Date:  2019-06-18       Impact factor: 9.423

7.  Targeted disruption of SPI3/Serpinb6 does not result in developmental or growth defects, leukocyte dysfunction, or susceptibility to stroke.

Authors:  Katrina L Scarff; Kheng S Ung; Harshal Nandurkar; Peter J Crack; Catherina H Bird; Phillip I Bird
Journal:  Mol Cell Biol       Date:  2004-05       Impact factor: 4.272

8.  A serpinB1 regulatory mechanism is essential for restricting neutrophil extracellular trap generation.

Authors:  Kalamo Farley; J Michael Stolley; Picheng Zhao; Jessica Cooley; Eileen Remold-O'Donnell
Journal:  J Immunol       Date:  2012-09-21       Impact factor: 5.422

9.  A Novel Serpin Regulatory Mechanism: SerpinB9 IS REVERSIBLY INHIBITED BY VICINAL DISULFIDE BOND FORMATION IN THE REACTIVE CENTER LOOP.

Authors:  Matthew S J Mangan; Catherina H Bird; Dion Kaiserman; Anthony Y Matthews; Corinne Hitchen; David L Steer; Philip E Thompson; Phillip I Bird
Journal:  J Biol Chem       Date:  2015-12-15       Impact factor: 5.157

10.  The human serpin proteinase inhibitor-9 self-associates at physiological temperatures.

Authors:  Lauren N Benning; James C Whisstock; Jiuru Sun; Phillip I Bird; Stephen P Bottomley
Journal:  Protein Sci       Date:  2004-07       Impact factor: 6.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.